HEPATITIS E VIRUS (HEV) - ANVISA Registration 10339840537

Access comprehensive regulatory information for HEPATITIS E VIRUS (HEV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840537 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until Nov 16, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VIRCELL S.L., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840537
2 Related Devices
Registration Details
ANVISA Registration Number: 10339840537
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

FAMÍLIA LIAISON® MUREX Anti-HEV IgM
Risk Class III

Registration Details

10339840537

25351527137202191

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

Nov 16, 2021

16/11/2031

09/18/2025 19:00:01

FAMÍLIA LIAISON® MUREX Anti-HEV IgM
Risk Class III

Registration Details

10339840537

25351527137202191

01896764000170

Company Information

Dates and Status

Nov 16, 2021

16/11/2031

09/18/2025 19:00:01